Perfluoroperhydrophenanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study.

Abstract

Fifty cases of retinal detachment with a giant retinal tear were managed using perfluoroperhydrophenanthrene (Vitreon) as an intraoperative and postoperative tool. The giant tear was less than 180 degrees in 76% of the eyes, greater than 180 degrees in 22%, and greater than 270 degrees in 2%. Proliferative vitreoretinopathy was present in 40%. Vitreon was used only intraoperatively in 84% of the eyes, and was left in 16% for up to 4 weeks. Intraoperative retinal reattachment was achieved in 98%. Retinal attachment was maintained in 88%, with a mean follow up of 8.6 months. Postoperative visual acuity was better than 20/400 in 52%. Postoperative complications included cataract in 23%, choroidal effusion in 2%, hypotony in 4%, and recurrent retinal detachment with proliferative vitreoretinopathy in 26%.

Statistics

0200400'99'01'03'05'07'09'11'13'15'17
Citations per Year

353 Citations

Semantic Scholar estimates that this publication has 353 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Millsap1993PerfluoroperhydrophenanthreneI, title={Perfluoroperhydrophenanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study.}, author={Claudette M. Millsap and Gholam A. Peyman and Neel Mehta and Maria D’Andrea Greve and Kyoung Ju Lee and Patrick E. Ma and Weldon A. Dunlap}, journal={Ophthalmic surgery}, year={1993}, volume={24 11}, pages={759-63} }